Question 1

How big is the Global Point-of-Care Molecular Diagnostics market?

Accepted Answer

According to Value Market Research, the global Global Point-of-Care Molecular Diagnostics market size was estimated at USD 9.25 Billion in 2025 and is expected to reach USD 9.88 Billion in 2026.

Question 2

What is the Global Point-of-Care Molecular Diagnostics market growth?

Accepted Answer

The global Global Point-of-Care Molecular Diagnostics market is expected to grow at a CAGR of 6.78% from 2026-2034 to reach USD 16.69 Billion by 2034.

Question 3

Which region holds the highest share in the Global Point-of-Care Molecular Diagnostics market?

Accepted Answer

North America held the highest share in the global Global Point-of-Care Molecular Diagnostics market.

Question 4

How is the Global Point-of-Care Molecular Diagnostics market segmented in the report?

Accepted Answer

The Global Point-of-Care Molecular Diagnostics market is segmented By Technology (PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based), By Application (Infectious Diseases (HIV POC, Clostridioides difficile POC, HBV POC, Pneumonia or Streptococcus-Associated Infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and Drug-Resistant TB POC, HSV POC, Other Infectious Diseases), Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications), By Test Location (OTC, POC), By End Use (Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities, Others).

Question 5

Which segment accounted for the largest point-of-care molecular diagnostics market share?

Accepted Answer

The PCR-based segment led the market by technology with a revenue share of 66.92% in 2025, supported by its high analytical accuracy, rapid turnaround time, and extensive clinical adoption for infectious disease diagnosis.

Question 6

What are the factors driving the point-of-care molecular diagnostics market?

Accepted Answer

Key drivers include the rising prevalence of infectious diseases, increasing demand for rapid and decentralized diagnostics, growing adoption of precision medicine, expanding healthcare infrastructure, and continuous technological advancements in portable molecular testing platforms that improve diagnostic accuracy and clinical decision-making.

Question 7

Who are the key players in the Global Point-of-Care Molecular Diagnostics market?

Accepted Answer

Some key players include F. Hoffmann-La Roche, Abbott, QIAGEN, Danaher Corporation and bioMérieux.